Sweet Financial Partners LLC Has $2.18 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jun 27th, 2023

Sweet Financial Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 55.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,604 shares of the healthcare conglomerate’s stock after acquiring an additional 1,651 shares during the period. UnitedHealth Group comprises approximately 0.6% of Sweet Financial Partners LLC’s holdings, making the stock its 28th largest holding. Sweet Financial Partners LLC’s holdings in UnitedHealth Group were worth $2,176,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock valued at $41,903,103,000 after purchasing an additional 851,994 shares during the period. Geode Capital Management LLC grew its stake in shares of UnitedHealth Group by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 16,858,436 shares of the healthcare conglomerate’s stock valued at $8,921,651,000 after purchasing an additional 247,997 shares during the period. Morgan Stanley grew its position in UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC grew its position in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Finally, Alliancebernstein L.P. grew its position in UnitedHealth Group by 4.1% during the 4th quarter. Alliancebernstein L.P. now owns 10,499,294 shares of the healthcare conglomerate’s stock worth $5,566,516,000 after acquiring an additional 414,032 shares during the last quarter. Institutional investors and hedge funds own 92.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on UNH shares. JPMorgan Chase & Co. decreased their price target on UnitedHealth Group from $595.00 to $562.00 in a research report on Tuesday, May 30th. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Royal Bank of Canada reissued an “outperform” rating and issued a $592.00 target price on shares of UnitedHealth Group in a research note on Monday, April 17th. Truist Financial lowered their target price on UnitedHealth Group from $610.00 to $580.00 in a research note on Wednesday, June 14th. Finally, Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Monday, April 17th. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $592.68.

UnitedHealth Group Stock Performance

UNH stock opened at $479.20 on Tuesday. The business’s 50-day moving average price is $484.66 and its two-hundred day moving average price is $491.47. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.71. The firm has a market cap of $446.15 billion, a PE ratio of 21.91, a P/E/G ratio of 1.39 and a beta of 0.68. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, topping the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The firm had revenue of $91.93 billion for the quarter, compared to analyst estimates of $89.77 billion. During the same period in the previous year, the company posted $5.49 earnings per share. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be paid a $1.88 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date is Thursday, June 15th. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.39%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Erin Mcsweeney sold 1,008 shares of UnitedHealth Group stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at $5,019,764.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock valued at $4,313,962 in the last 90 days. 0.35% of the stock is currently owned by company insiders.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.